247 related articles for article (PubMed ID: 33910579)
1. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.
Raucci FJ; Xu M; George-Durrett K; Crum K; Slaughter JC; Parra DA; Markham LW; Soslow JH
J Cardiovasc Magn Reson; 2021 Apr; 23(1):48. PubMed ID: 33910579
[TBL] [Abstract][Full Text] [Related]
2. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
3. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD
Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096
[TBL] [Abstract][Full Text] [Related]
4. Localized strain characterization of cardiomyopathy in Duchenne muscular dystrophy using novel 4D kinematic analysis of cine cardiovascular magnetic resonance.
Earl CC; Pyle VI; Clark SQ; Annamalai K; Torres PA; Quintero A; Damen FW; Hor KN; Markham LW; Soslow JH; Goergen CJ
J Cardiovasc Magn Reson; 2023 Feb; 25(1):14. PubMed ID: 36793101
[TBL] [Abstract][Full Text] [Related]
5. Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy.
Olivieri LJ; Kellman P; McCarter RJ; Cross RR; Hansen MS; Spurney CF
J Cardiovasc Magn Reson; 2016 Oct; 18(1):72. PubMed ID: 27788681
[TBL] [Abstract][Full Text] [Related]
6. Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy.
Soslow JH; Damon SM; Crum K; Lawson MA; Slaughter JC; Xu M; Arai AE; Sawyer DB; Parra DA; Damon BM; Markham LW
J Cardiovasc Magn Reson; 2016 Jan; 18():5. PubMed ID: 26795569
[TBL] [Abstract][Full Text] [Related]
7. Derivation and validation of diagnostic models for myocardial fibrosis in duchenne muscular dystrophy: assessed by multi-parameter cardiovascular magnetic resonance.
Zhou ZQ; Xu HY; Fu H; Xu K; Xu R; Cai XT; Guo YK
Orphanet J Rare Dis; 2023 Dec; 18(1):388. PubMed ID: 38082428
[TBL] [Abstract][Full Text] [Related]
8. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
9. Global, segmental and layer specific analysis of myocardial involvement in Duchenne muscular dystrophy by cardiovascular magnetic resonance native T1 mapping.
Xu K; Xu HY; Xu R; Xie LJ; Yang ZG; Yu L; Zhou B; Fu H; Liu H; Cai XT; Guo YK
J Cardiovasc Magn Reson; 2021 Oct; 23(1):110. PubMed ID: 34645467
[TBL] [Abstract][Full Text] [Related]
10. Elevated Myocardial Extracellular Volume Fraction in Duchenne Muscular Dystrophy.
Starc JJ; Moore RA; Rattan MS; Villa CR; Gao Z; Mazur W; Jefferies JL; Taylor MD
Pediatr Cardiol; 2017 Oct; 38(7):1485-1492. PubMed ID: 28762167
[TBL] [Abstract][Full Text] [Related]
11. Myocardial Strain Using Cardiac MR Feature Tracking and Speckle Tracking Echocardiography in Duchenne Muscular Dystrophy Patients.
Siegel B; Olivieri L; Gordish-Dressman H; Spurney CF
Pediatr Cardiol; 2018 Mar; 39(3):478-483. PubMed ID: 29188318
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive cardiac magnetic resonance T1, T2, and extracellular volume mapping to define Duchenne cardiomyopathy.
Sunthankar SD; George-Durrett K; Crum K; Slaughter JC; Kasten J; Raucci FJ; Markham LW; Soslow JH
J Cardiovasc Magn Reson; 2023 Jul; 25(1):44. PubMed ID: 37517994
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular deformation and myocardial fibrosis in pediatric patients with Duchenne muscular dystrophy.
Kerstens TP; van Everdingen WM; Habets J; van Dijk APJ; Helbing WA; Thijssen DHJ; Udink Ten Cate FEA
Int J Cardiol; 2023 Oct; 388():131162. PubMed ID: 37433407
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy.
Henson SE; Lang SM; Khoury PR; Tian C; Rutter MM; Urbina EM; Ryan TD; Taylor MD; Alsaied T
J Am Heart Assoc; 2021 Oct; 10(19):e021037. PubMed ID: 34569261
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.
Hor KN; Taylor MD; Al-Khalidi HR; Cripe LH; Raman SV; Jefferies JL; O'Donnell R; Benson DW; Mazur W
J Cardiovasc Magn Reson; 2013 Dec; 15(1):107. PubMed ID: 24359596
[TBL] [Abstract][Full Text] [Related]
16. Right Ventricular Function and T1-Mapping in Boys With Duchenne Muscular Dystrophy.
Dual SA; Maforo NG; McElhinney DB; Prosper A; Wu HH; Maskatia S; Renella P; Halnon N; Ennis DB
J Magn Reson Imaging; 2021 Nov; 54(5):1503-1513. PubMed ID: 34037289
[TBL] [Abstract][Full Text] [Related]
17. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
[TBL] [Abstract][Full Text] [Related]
18. Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in duchenne muscular dystrophy.
Tandon A; Villa CR; Hor KN; Jefferies JL; Gao Z; Towbin JA; Wong BL; Mazur W; Fleck RJ; Sticka JJ; Benson DW; Taylor MD
J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25814625
[TBL] [Abstract][Full Text] [Related]
19. Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging.
Lang SM; Shugh S; Mazur W; Sticka JJ; Rattan MS; Jefferies JL; Taylor MD
Pediatr Cardiol; 2015 Oct; 36(7):1495-501. PubMed ID: 25976773
[TBL] [Abstract][Full Text] [Related]
20. Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality.
Cardona A; Arnold WD; Kissel JT; Raman SV; Zareba KM
J Cardiovasc Magn Reson; 2019 May; 21(1):26. PubMed ID: 31046780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
